Heart Failure

Our round-up of the latest generic products.

A new analysis explores the characteristics of patients with permanent versus non-permanent atrial fibrillation, as well as those whose condition is controlled versus uncontrolled.

A new study estimates the costs of treating atrial fibrillation as well as the comparative costs of treating it with warfarin and newer oral anticoagulants.

The results of a recent study identified a relationship between cardiovascular disease and cognitive decline in postmenopausal women.

An overview of "Get with the Guidelines " AFIB," a quality-improvement program created by the American Heart Association for health care providers.

OTC case studies involving vitamin E supplementation, omega-3 fatty acid supplementation, smoking cessation, and weight-loss medication.

Newly released lipid guidelines have introduced a variety of changes in how clinicians determine whether patients should receive statins.

Recommendations regarding OTC products for treatment of chronic dry cough, cold prevention, general symptom relief, and nasal congestion.

Pharmacists working along with other health care providers can help improve outcomes for heart failure patients, according to the results of a pair of studies presented at the Heart Failure Society of America meeting.

Although obesity is a known risk factor for cardiac disease, several recent studies have found that obesity does not seem to be an indicator of premature death.

Heart failure patients younger than 60 years of age who took warfarin experienced significantly fewer adverse events than those who took aspirin, a new study finds.

Middle-aged men who took statins for 5 years had a substantially lower hospitalization rate and reduced health care costs over a 15-year period.

The primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.

A new study finds that increased access to MTM services for Medicare Part D beneficiaries with chronic conditions could increase medication adherence, reduce costs, and improve outcomes.

A study finds that use of sulfonylureas in the period leading up to an acute coronary syndrome is not associated with increased risk of death or heart failure.

This triple therapy can increase the risk of acute renal failure.

More than half a million Americans die from heart disease each year, but increased attention to its risk factors can help reduce this number.

As part of an interdisciplinary team at Pennsylvania Hospital, clinical pharmacists helped improve performance on 9 medication-related core measures.

This video, from the Cleveland Clinic, discusses a syndrome in which generally healthy people who drink more than usual at the holidays can experience heart problems.

Although pharmacist interventions didn't reduce hospitalizations or death rates, they did result in more patients getting the recommended medications.